|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12P 21/00 | |
| C07K 14/745 | |||
| C12N 9/64 |
| (11) | Number of the document | 1745141 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05766825.3 |
| Date of filing the European patent application | 2005-05-03 | |
| (97) | Date of publication of the European application | 2007-01-24 |
| (45) | Date of publication and mention of the grant of the patent | 2010-01-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2005/052024 |
| Date | 2005-05-03 |
| (87) | Number | WO 2005/111225 |
| Date | 2005-11-24 |
| (30) | Number | Date | Country code |
| 200400712 | 2004-05-04 | DK | |
| 200400882 | 2004-06-04 | DK |
| (72) |
KLAUSEN, Niels Kristian, DK
RASMUSSEN, Daniel, DK
|
| (73) |
Novo Nordisk Health Care AG,
Andreasstrasse 15, 8050 Zürich,
CH
|
| (54) | O-LINKED GLYCOFORMS OF FAKTOR VII AND METHOD TO MANUFACTURE THEM |
| O-LINKED GLYCOFORMS OF FAKTOR VII AND METHOD TO MANUFACTURE THEM |